Literature DB >> 29688109

Power Output and Pacing During International Cross-Country Mountain Bike Cycling.

Cyril Granier, Chris R Abbiss, Anaël Aubry, Yvon Vauchez, Sylvain Dorel, Christophe Hausswirth, Yann Le Meur.   

Abstract

PURPOSE: To characterize the physiological profiles of elite cross-country mountain-bike (XCO-MTB) cyclists and to examine their pacing and power-output (PO) distribution during international races.
METHODS: Over 2 competitive seasons, 8 male XCO-MTB cyclists (VO2max 79.9 [5.2] mL·min-1·kg-1, maximal aerobic power [MAP] 411 [18] W and 6.3 [0.4] W·kg-1) regularly undertook incremental tests to assess their PO and heart rate (HR) at first and second ventilatory thresholds (VT1 and VT2) and at VO2max. During the same period, their PO, HR, speed, and cadence were recorded over 13 international races (total of 30 recorded files).
RESULTS: Mean PO, speed, cadence, and HR during the races were 283 (22) W (4.31 [0.32] W·kg-1, 68% [5%] MAP), 19.7 (2.1) km·h-1, 68 (8) rpm, and 172 (11) beats·min-1 (91% [2%] HRmax), respectively. The average times spent below 10% of MAP, between 10% of MAP and VT1, between VT1 and VT2, between VT2 and MAP, and above MAP were 25% (5%), 21% (4%), 13% (3%), 16% (3%), and 26% (5%), respectively. Both speed and PO decreased from the start loop to lap 1 before stabilizing until the end of the race.
CONCLUSIONS: Elite off-road cyclists demonstrated typical values of world-class endurance cyclists with an excellent power-to-mass ratio. This study demonstrated that XCO-MTB races are performed at higher intensities than reported in previous research and are characterized by a fast start followed by an even pace.

Keywords:  elite athletes; endurance performance; off-road cycling; performance analysis

Mesh:

Year:  2018        PMID: 29688109     DOI: 10.1123/ijspp.2017-0516

Source DB:  PubMed          Journal:  Int J Sports Physiol Perform        ISSN: 1555-0265            Impact factor:   4.010


  8 in total

1.  Understanding the Physiological Requirements of the Mountain Bike Cross-Country Olympic Race Format.

Authors:  Arnaud Hays; Simon Devys; Denis Bertin; Laurie-Anne Marquet; Jeanick Brisswalter
Journal:  Front Physiol       Date:  2018-08-09       Impact factor: 4.566

2.  Do Surface Slope and Posture Influence Lower Extremity Joint Kinetics during Cycling?

Authors:  Yunqi Tang; Donghai Wang; Yong Wang; Keyi Yin; Cui Zhang; Limin Zou; Yu Liu
Journal:  Int J Environ Res Public Health       Date:  2020-04-21       Impact factor: 3.390

3.  Pacing and Positioning Strategies During an Elite Fixed-Gear Cycling Criterium.

Authors:  Nicolas Babault; Christos Paizis; Mary Trimble; David A Trimble; Carole Cometti
Journal:  Front Sports Act Living       Date:  2020-10-08

4.  Case Report: Effects of Multiple Seasons of Heavy Strength Training on Muscle Strength and Cycling Sprint Power in Elite Cyclists.

Authors:  Bent R Rønnestad
Journal:  Front Sports Act Living       Date:  2022-04-25

5.  Creatine Kinase and Myoglobin Plasma Levels in Mountain Bike and Road Cyclists 1 h after the Race.

Authors:  Rafal Hebisz; Jacek Borkowski; Paulina Hebisz
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

Review 6.  Current Perspectives of Cross-Country Mountain Biking: Physiological and Mechanical Aspects, Evolution of Bikes, Accidents and Injuries.

Authors:  Rhaí André Arriel; Hiago L R Souza; Jeffer Eidi Sasaki; Moacir Marocolo
Journal:  Int J Environ Res Public Health       Date:  2022-10-01       Impact factor: 4.614

7.  Race Performance Prediction from the Physiological Profile in National Level Youth Cross-Country Cyclists.

Authors:  Gerardo Gabriel Mirizio; Rodrigo Muñoz; Leandro Muñoz; Facundo Ahumada; Juan Del Coso
Journal:  Int J Environ Res Public Health       Date:  2021-05-21       Impact factor: 3.390

8.  Exercise Intensity and Pacing Pattern During a Cross-Country Olympic Mountain Bike Race.

Authors:  Steffan Næss; Ove Sollie; Øyvind Nøstdahl Gløersen; Thomas Losnegard
Journal:  Front Physiol       Date:  2021-07-19       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.